Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Basic): 2016-2024

Historic EPS (Basic) for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -$0.01.

  • Organogenesis Holdings' EPS (Basic) rose 22.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 86.62%. This contributed to the annual value of -$0.01 for FY2024, which is 125.00% down from last year.
  • Organogenesis Holdings' EPS (Basic) amounted to -$0.01 in FY2024, which was down 125.00% from $0.04 recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' EPS (Basic) peaked at $0.73 during FY2021, and registered a low of -$0.01 during FY2024.
  • Its 3-year average for EPS (Basic) is $0.05, with a median of $0.04 in 2023.
  • In the last 5 years, Organogenesis Holdings' EPS (Basic) spiked by 356.25% in 2021 and then crashed by 125.00% in 2024.
  • Yearly analysis of 5 years shows Organogenesis Holdings' EPS (Basic) stood at $0.16 in 2020, then spiked by 356.25% to $0.73 in 2021, then tumbled by 83.56% to $0.12 in 2022, then tumbled by 66.67% to $0.04 in 2023, then slumped by 125.00% to -$0.01 in 2024.